499 A first-in-human, phase 1/2 clinical trial of TK-8001, a MAGE-A1 directed T cell receptor in patients with advanced-stage solid tumors (The “IMAG1NE”-trial)
oleh: Fiona Thistlethwaite, Sylvie Rottey, Emiliano Calvo, Antonia Busse, Martin Wermke, Ralf Wolter, Thomas Blankenstein, Vivian Scheuplein, Elisa Kieback, Matthias Obenaus, Eugen Leo, Ioannis Gavvovidis, Marie-Luise Goebeler, Nuria Kotecki, Carolina Perdomo-Ortiz
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.